Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2010
02/25/2010US20100048565 Benzimidazole derivatives
02/25/2010US20100048543 Pyrimidine compounds having ties (tek) inhibitory activity
02/25/2010US20100048536 Novel Substituted Diaryl Azepine Derivatives as Integrin Ligands
02/25/2010US20100044695 Compound for organic electroluminescent device and organic electroluminescent device
02/25/2010CA2734787A1 Substituted 5-aminopyrazoles and use thereof
02/25/2010CA2734487A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010CA2734486A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/24/2010EP2157090A1 Pyrazinamide compound
02/24/2010EP2157089A1 The therapeutic uses of imidazol-5-carboxylic acid derivatives
02/24/2010EP2157088A1 Indicyanine dyes and the derivatives thereof for analysing biological micromolecules
02/24/2010EP2157081A1 Indolinones substituted in six locations, their manufacture and their application as medicine
02/24/2010EP2155730A2 Aminopyrimidines useful as kinase inhibitors
02/24/2010EP2155729A1 Prolinamide-tetrazole derivatives as nk3 receptor antagonists
02/24/2010EP2155728A2 Heterocyclic indazole derivatives
02/24/2010EP2155727A1 N-[6-amino-5-(phenyl)pyrazin-2-yl]-isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
02/24/2010EP2155726A1 Phthalazinone derivatives and their use as medicament to treat cancer
02/24/2010EP2155725A1 Synthesis of substituted-3-aminopyrazoles
02/24/2010EP2155722A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
02/24/2010EP2155720A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
02/24/2010EP2155719A1 Azacyclylbenzamide derivatives as histamine-3 antagonists
02/24/2010EP2155717A1 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
02/24/2010EP2155714A2 Substituted aromatic heterocyclic compounds as fungicides
02/24/2010EP2155690A1 Indazolamide derivatives
02/24/2010EP2155676A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
02/24/2010EP2155675A1 Kinase inhibitors, compositions thereof, and methods of use therewith
02/24/2010EP2155666A1 Azetidine derivatives and their use as prostaglandin e2 antagonists
02/24/2010EP1971580B1 Piperazine compounds with a herbicidal action
02/24/2010EP1931335B1 Hexahydro cyclooctyl pyrazole cannabinoid modulators
02/24/2010EP1625121B1 Pyrimidine derivatives for the treatment of abnormal cell growth
02/24/2010EP1585728B1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
02/24/2010EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use
02/24/2010EP1000999B1 Compounds for organic el devices and organic el devices
02/24/2010CN101657442A Improved process for preparing irbesartan
02/24/2010CN100591676C 2- and 2,5-substituted phenylketo-enols
02/24/2010CN100591666C 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI
02/23/2010US7667046 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces
02/23/2010US7667041 Cinnamide compound
02/23/2010US7667035 (R)-2-(-3-amino-piperidin-1-yl)-3-(but-2-ynyl)-5-(4-methyl-quinazolin-2-ylmethyl)-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibitors of dipeptidylpeptidase IV (DPP IV)
02/23/2010US7666895 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
02/23/2010US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
02/23/2010US7666871 3-Methyl-6-(4-{5-methyl-4-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-oxazol-2-yl}-phenyl)-pyridazine; for treatment of obesity, cognitive deficiencies, narcolepsy
02/23/2010US7666870 4-[5-(piperazine-1-carbonyl)-pyridin-2-ylmethyl]-2H-phthalazin-1-one; enzyme inhibitor of poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1); anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; and multiple sclerosis
02/23/2010US7666869 Nitrogen-containing 5-membered ring compound
02/23/2010US7666868 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
02/23/2010US7666862 2,4-Diphenyl-1-(hexamethylenimin-4-ylaminocarbonyl)dihydropyrrole derivatives that are useful for treating cancer
02/23/2010US7666857 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3′-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
02/23/2010CA2462289C Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
02/18/2010WO2010019832A2 Amide-extended crosslinking compounds and methods for use thereof
02/18/2010WO2010019417A2 Chymase inhibitors
02/18/2010WO2010019210A2 Halofuginone analogs for inhibition of trna synthetases and uses thereof
02/18/2010WO2010018329A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
02/18/2010WO2010018328A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
02/18/2010WO2010018214A1 Pyrrolidinone derivatives useful for the treatement of psychotic and neurological disorders
02/18/2010WO2010017902A1 Insecticidal 4-phenyl-1h-pyrazoles
02/18/2010WO2010017870A1 Bicyclic triazole derivatives for treating tumors
02/18/2010US20100041897 Process for preparing a crystalline form of candesartan cilexetil
02/18/2010US20100041867 Reversible pegylated drugs
02/18/2010US20100041722 Organic compounds
02/18/2010US20100041709 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
02/18/2010US20100041686 4,5-dihydro-oxazol-2yl derivatives
02/18/2010US20100041674 Hcv protease inhibitors and uses thereof
02/18/2010US20100041673 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands
02/18/2010US20100041669 4-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands
02/18/2010US20100041664 Bicyclic lactam factor viia inhibitors useful as anticoagulants
02/18/2010US20100041663 Organic Compounds as Smo Inhibitors
02/18/2010US20100041660 Novel 2-pyridinecarboxamide derivatives
02/18/2010US20100041655 Triazole derivative
02/18/2010US20100041654 Pyrimidine Derivatives And Their Use As CB2 Modulators
02/18/2010US20100041652 Tyrosine kinase inhibitors
02/18/2010US20100041639 Cyclic malonamides as inhibitors of a beta protein production
02/18/2010US20100041638 Chemical Compounds 293
02/18/2010US20100041568 Tripodal cyclohexane derivatives and their use as carbohydrate receptors
02/18/2010US20100041555 3-Phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same
02/18/2010US20100040976 Heat-sensitive imaging element
02/18/2010US20100040547 Dyes and precursors and conjugates thereof
02/18/2010DE102008041216A1 New substituted indole-carboxamide compounds useful e.g. in plant protection, for combating animal pests, arthropods, nematodes and plant diseases, and for protecting industrial materials against attack and destruction by insects
02/18/2010CA2737219A1 Halofuginone analogs for inhibition of trna synthetases and uses thereof
02/18/2010CA2734082A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
02/18/2010CA2733958A1 Insecticidal 4-phenyl-1h-pyrazoles
02/18/2010CA2733941A1 Bicyclic triazole derivatives for the treatment of tumours
02/18/2010CA2733397A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
02/18/2010CA2733128A1 Chymase inhibitors
02/17/2010EP2154135A1 Therapeutic agent for cerebral infarction
02/17/2010EP2153832A2 Heterocyclic aspartyl protease inhibitors
02/17/2010EP2153819A2 Compositions containing therapeutically active components having enhanced solubility
02/17/2010EP2152701A1 Phenyl amino pyrimidine compounds and uses thereof
02/17/2010EP2152696A1 Aminopyrimidines useful as kinase inhibitors
02/17/2010EP2152695A2 Gamma secretase modulators
02/17/2010EP2152674A1 Benzimidazolone chymase inhibitors
02/17/2010EP2152669A1 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
02/17/2010EP2152664A1 Dipeptide analogs as coagulation factor inhibitors
02/17/2010EP2152370A1 Aryl ether pyridazinone derivatives
02/17/2010EP2152272A2 Novel 2,3-diamino-quinazolinone derivatives and their medical use
02/17/2010EP2152079A1 Heterocyclic compounds and uses thereof
02/17/2010EP1902026B1 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
02/17/2010EP1549318B1 Crystal structure of aurora-2 protein and binding pockets thereof
02/17/2010EP1511737B1 Aryloximes
02/17/2010CN101652360A nitro-imidazole hypoxia imaging agents
02/17/2010CN101652359A Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
02/17/2010CN101648947A 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors